Disposition Kinetics of Taxanes in Peritoneal Dissemination
Treatment of cancers in the abdominal cavity, such as peritoneal dissemination, is difficult, but in principle intraperitoneal administration of anticancer drugs is expected to be preferable to systemic administration. Taxane anticancer drugs are used to treat gastric cancer patients with peritoneal...
Saved in:
| Main Authors: | Ken'ichi Miyamoto, Tsutomu Shimada, Kazuki Sawamoto, Yoshimichi Sai, Yutaka Yonemura |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2012-01-01
|
| Series: | Gastroenterology Research and Practice |
| Online Access: | http://dx.doi.org/10.1155/2012/963403 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Peritoneal Metastases
by: Yutaka Yonemura, et al.
Published: (2012-01-01) -
Influence of Flunixin on the Disposition Kinetic of Cefepime in Goats
by: Mohamed El-Hewaity
Published: (2014-01-01) -
Taxanes – The backbone of medical oncology
by: Wesley M Jose
Published: (2020-01-01) -
Effects of taxane-anthracycline and taxane only treatment on cardiac function in breast cancer—a retrospective cohort study
by: Árpád Kézdi, et al.
Published: (2025-04-01) -
Disposition Kinetics of Levofloxacin in Sheep after Intravenous and Intramuscular Administration
by: Ayman Goudah, et al.
Published: (2010-01-01)